Ann: Scheme Booklet Registered by ASIC, page-7

First 7 Last

Share
Profile

Follow
Jeffro1990

554 Posts.

159

21/03/23

07:17

Post #: 66870520
Share

Originally posted by Bluegoose: ↑

The offer price has heavily influenced the "Independent" report.

They have come up with a valuation, surprise surprise around the offer price with a range slightly either side of it.

I would consider the top end of the range in the absence of a superior bid.

Tim and the board have been totally incompetent to give up all the land and all the other projects as part of the Scheme. I can't think of any other company that has done this and usually the main project is sold with the balance of land / projects retained to try and create more value for shareholders.

But ongoing value creation does not appear to be a priority for Tim and the board and they are more interested in cashing in their free options and having a nice holiday!!

I'm sure a long holiday will happen for them - whether they want one or not as I can't imagine any company hiring these guys again!!. Maybe some desperate and dodgy penny stock but that's about it.

Expand

I agree, these guys will stink like a pet dog that’s found something dead to roll in.

Management have taken the most direct path to avoiding any real work they could find.

ESS Price at posting: 48.5¢ Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: Scheme Booklet Registered by ASIC, page-7

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News